Svas Biosana S.p.A. (BIT:SVS)
8.28
-0.12 (-1.43%)
At close: Jun 5, 2025, 5:30 PM CET
Svas Biosana Revenue
In the year 2024, Svas Biosana had annual revenue of 122.29M EUR with 0.54% growth. Svas Biosana had revenue of 63.25M in the half year ending December 31, 2024, with 15.37% growth.
Revenue
122.29M
Revenue Growth
+0.54%
P/S Ratio
0.34
Revenue / Employee
373.97K
Employees
327
Market Cap
41.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 122.29M | 656.90K | 0.54% |
Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.41B |
DiaSorin | 1.21B |
Amplifon | 2.42B |
Philogen | 77.65M |
EL.En. | 577.19M |
Pharmanutra | 116.15M |
Garofalo Health Care | 470.20M |
Safilo Group | 993.22M |